|
|
Volumn 16, Issue 2, 2000, Pages 123-124
|
|
Drug therapy review: Palivizumab (Synagis®) for prevention of respiratory illness in children
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
MONOCLONAL ANTIBODY;
PALIVIZUMAB;
AGE;
ARTICLE;
HUMAN;
IMMUNOLOGY;
INFANT;
INTENSIVE CARE;
METHODOLOGY;
NEWBORN;
NURSING;
PEDIATRIC NURSING;
PRESCHOOL CHILD;
VIROLOGY;
VIRUS INFECTION;
AGE FACTORS;
ANTIBODIES, MONOCLONAL;
ANTIVIRAL AGENTS;
CHILD, PRESCHOOL;
CRITICAL CARE;
HUMANS;
INFANT;
INFANT, NEWBORN;
PEDIATRIC NURSING;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
|
|
EID: 0034174746
PISSN: 09643397
EISSN: None
Source Type: Journal
DOI: 10.1054/iccn.1999.1505 Document Type: Article |
|
Times cited : (2)
|
|
References (1)
|
